Chemotherapy – IST Istituto Nazionale per la Ricerca sul Cancro

Survival:?
Toxicity Grade:4
Treatments:Chemotherapy
Drugs:Eloxatin
Raltitrexed
Country:Italy
City/State/Province:Genoa
Hospital:IST Istituto Nazionale per la Ricerca sul Cancro
Journal:Link
Date:11/2001

 

Description:
Patients: This study involved 11 patients with inoperable malignant pleural mesothelioma. None of the patients had been administered chemotherapy before.

Treatment: The treatment consisted of two chemotherapy drugs, oxaliplatin (eloxatin) and raltitrexed.

Toxicity: Grade 3 or 4 toxicities included gastrointestinal, diarrhea, asthenia, neurotoxicity, and transaminase elevation.

Results: Overall survival was not discussed, but the median time to progression (when the cancers grew) was 16.5 weeks.

Correspondence: Dr. Roberto Maisano

Get your free copy of
“Surviving Mesothelioma” Today!